Pyrazolyl-Pyrimidines as Potassium Channel Modulating Agents and Their Medical Use
    7.
    发明申请
    Pyrazolyl-Pyrimidines as Potassium Channel Modulating Agents and Their Medical Use 审中-公开
    吡唑基 - 嘧啶作为钾通道调节剂及其医疗用途

    公开(公告)号:US20090036475A1

    公开(公告)日:2009-02-05

    申请号:US11886775

    申请日:2006-03-20

    CPC分类号: C07D403/04

    摘要: This invention relates to novel potassium channel modulating agents, and their use in the preparation of pharmaceutical compositions.Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels, in particular respiratory diseases, epilepsy, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, urinary incontinence, bladder outflow obstruction, irritable bowel syndrome, gastrointestinal dysfunction, secretory diarrhoea, ischaemia, cerebral ischaemia, ischaemic heart disease, angina pectoris, coronary heart disease, traumatic brain injury, psychosis, schizophrenia, anxiety, depression, dementia, memory and attention deficits, Alzheimer's disease, dysmenorrhea, narcolepsy, Reynaud's disease, intermittent claudication, Sjorgren's syndrome, migraine, arrhythmia, hypertension, absence seizures, myotonic muscle dystrophia, xerostomi, diabetes type II, hyperinsulinemia, premature labour, baldness, cancer, immune suppression or pain.

    摘要翻译: 本发明涉及新型钾通道调节剂及其在制备药物组合物中的用途。 此外,本发明涉及可用于治疗或缓解与钾通道活动相关的疾病或病症的药物组合物,特别是呼吸系统疾病,癫痫,惊厥,血管痉挛,冠状动脉痉挛,肾脏疾病,多囊肾病,膀胱 痉挛,尿失禁,膀胱流出阻塞,肠易激综合征,胃肠功能障碍,分泌性腹泻,局部缺血,脑缺血,缺血性心脏病,心绞痛,冠心病,创伤性脑损伤,精神病,精神分裂症,焦虑,抑郁,痴呆,记忆 注意缺陷,阿尔茨海默氏症,痛经,发作性睡病,雷诺病,间歇性跛行,Sjorgren综合征,偏头痛,心律失常,高血压,不存在癫痫发作,强直肌营养不良,口干燥症,II型糖尿病,高胰岛素血症,早产,秃发,癌症,免疫抑制 或疼痛。